Delivery Time: ~7 days
Arimidex 1 mg
|Q-ty||Price||per unit||Bonus pills|
|28 tablets||$342.56||$ 12.23||ADD TO CART|
What is Arimidex?
Arimidex is an orally-active non-steroidal breast cancer drug that belongs to the class of aromatase inhibitors. Its active ingredient is Anastrazole, which works by decreasing estrogen levels in the body helping to slow the growth of breast tumors and shrink their size. The drug comes in tablet form with 1 mg of strength and presupposes chronic administration. It was approved by FDA in 1995.
When is Arimidex inidicated?
Arimidex is indicated for the adjuvant therapy of hormone receptor-positive breast cancer especially in post-menopausal women. It is prescribed as a first-line therapy of locally advanced or metastatic breast cancer that is either hormone receptor-positive or hormone receptor unknown; and as a second-line therapy of advanced cancer that hasn’t responded to Tamoxifen. The drug is not approved for use in children, adolescents and men.
How to take Arimidex?
Arimidex is administered orally in a dose of 1 mg once daily. Tablets can be taken with or without food but preferably at one and the same time each day to maintain an even level of the drug in blood. The duration of treatment depends on the cancer stage, tumor progression and concomitantly received medications. Women with early breast cancer can receive the drug for as long as 5 years. Women with advanced breast cancer should receive the drug until tumor grows or metastasizes.
What are Arimidex side effects?
Arimidex is usually well tolerated and has fewer side effects than similar drugs of other classes. If any side effects occur, they are typically mild and easily treated, and namely headache, nausea, hot flashes, fatigue, dry mouth, sore throat, bone weakness, body aches and pains. Serious side effects that should be immediately reported to the healthcare provider are difficulty breathing, high blood pressure, allergic reactions and unexplained vaginal bleeding.
When is Arimidex contraindicated?
Arimidex is contraindicated to pregnant women and women who have previously manifested allergic reactions to Anastrazole or any of the drug excipients. The drug shouldn’t be administered together with Tamoxifen. Caution should be exercised when prescribing the drug to patients with pre-existing ischemic heart disease. Monitoring of bone mineral density is advised while receiving the drug.